RankingsPricing
  1. US-listed companies
  2. TEVA PHARMACEUTICAL INDUSTRIES LTD
  3. Financials
  4. Gross margin (%)

TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA

Market cap
$27.8B
P/E ratio
SummaryFinancials
Period EndGross margin (%) YoY (%)
Dec 31, 202448.7+1.03%
Dec 31, 202348.2+3.26%
Dec 31, 202246.7-2.31%
Dec 31, 202147.8+3.13%
Dec 31, 202046.4+3.91%
Dec 31, 201944.6+1.43%
Dec 31, 201844-9.01%
Dec 31, 201748.4-10.68%
Dec 31, 201654.1-6.30%
Dec 31, 201557.8+5.95%
Dec 31, 201454.5+3.47%
Dec 31, 201352.7+0.53%
Dec 31, 201252.4+0.90%
Dec 31, 201152-7.59%
Dec 31, 201056.2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)